During the past decade, Prostate Oncology Specialists, Inc. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prostate Oncology Specialists, Inc." #1 sponsor was "Matrix Biomed, Inc." with 2 trials, followed by "Abbott" with 1 trials sponsored, "Achieve Life Sciences" with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prostate Oncology Specialists, Inc." #1 collaborator was "Achieve Life Sciences" with 1 trials as a collaborator, "Dendreon" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoosier Cancer Research Network" with 1 trials as a collaborator and "Prostate Oncology Specialists" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Prostate Oncology Specialists, Inc." are "Prostate Cancer" (9 trials), "Prostate Cancer Metastatic" (3 trials), "Adenocarcinoma" (1 trials), "Biochemical Recurrent Prostate Cancer" (1 trials) and "Castrate Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Prostate Oncology Specialists, Inc." in a lesser frequency.

Most popular intervention types in "Prostate Oncology Specialists, Inc." are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Enzalutamide" (2 trials), "Prednisone" (2 trials), "Sipuleucel-T" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prostate Oncology Specialists, Inc." are 13 trials for "Male" genders.

Currently, there are NaN active trials in "Prostate Oncology Specialists, Inc.". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Prostate Oncology Specialists, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Prostate Oncology Specialists, Inc., 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".